Ambitious Belgian biotech goes shopping in US 'built to be bought' market

EURACTIV - Belgian biopharma firm UCB has entered one of the most aggressive strategic expansion phases in its recent history, using acquisitions and partnerships across the United States, China and Europe to rapidly expand its biotechnology capabilities.. Read more

[Photo by Solskin / Getty Images]